These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 33566707

  • 21. Eluxadoline for Irritable Bowel Syndrome with Diarrhea.
    Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS.
    N Engl J Med; 2016 Jan 21; 374(3):242-53. PubMed ID: 26789872
    [Abstract] [Full Text] [Related]

  • 22. Modern Management of Irritable Bowel Syndrome: More Than Motility.
    Tack J, Vanuytsel T, Corsetti M.
    Dig Dis; 2016 Jan 21; 34(5):566-73. PubMed ID: 27331917
    [Abstract] [Full Text] [Related]

  • 23. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.
    Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS.
    Clin Gastroenterol Hepatol; 2017 Jul 21; 15(7):1021-1029.e6. PubMed ID: 28167156
    [Abstract] [Full Text] [Related]

  • 24. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
    Olden KW, Chey WD, Shringarpure R, Paul Nicandro J, Chuang E, Earnest DL.
    Curr Med Res Opin; 2019 Mar 21; 35(3):461-472. PubMed ID: 30293448
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.
    Wechsler EV, Shah ED.
    Drugs; 2021 Nov 21; 81(17):1953-1968. PubMed ID: 34727333
    [Abstract] [Full Text] [Related]

  • 33. New treatment options for irritable bowel syndrome with predominant diarrhea.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb 21; 24(1):25-30. PubMed ID: 27875419
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline.
    Gawron AJ, Bielefeldt K.
    Clin Gastroenterol Hepatol; 2018 Mar 21; 16(3):378-384.e2. PubMed ID: 28804032
    [Abstract] [Full Text] [Related]

  • 36. Evidence-based management of irritable bowel syndrome with diarrhea.
    Pimentel M.
    Am J Manag Care; 2018 Jan 21; 24(3 Suppl):S35-S46. PubMed ID: 29372991
    [Abstract] [Full Text] [Related]

  • 37. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
    Moshiree B, Heidelbaugh JJ, Sayuk GS.
    Adv Ther; 2022 Sep 21; 39(9):4003-4020. PubMed ID: 35869354
    [Abstract] [Full Text] [Related]

  • 38. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective.
    Vera I, Júdez FJ.
    Rev Esp Enferm Dig; 2017 Nov 21; 109(11):788-794. PubMed ID: 28747053
    [Abstract] [Full Text] [Related]

  • 39. Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations.
    Lacy BE, Moreau JC.
    J Am Assoc Nurse Pract; 2016 Jul 21; 28(7):393-404. PubMed ID: 27436200
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.